Induced Pluripotent Stem Cell Research Permits “Disease in a Dish” Research of Parkinson’s

Another big breakthrough on the IPSC front: Skin cells from a patient with Parkinson’s—a variety caused by a genetic condition—have been turned into neural cells, and then studied as the Parkinson’s destroys the tissue.  From the story:

There are no cures because research has been very hard to do, for two specific reasons: Only humans get the disease, so laboratory animals aren’t good models for testing. And it is impossible to extract cells from deep inside the brains of patients. By the time patients die, the brain cells are dead, too. “It is a huge bottleneck to research,” Langston said.

But a new technique has changed all that. By inserting certain genes into skin cells, scientists can turn back the clock, causing them to revert to “induced pluripotent stem (iPS) cells” — with embryonic-like traits. Then they are coaxed into becoming mature cells, such as neurons. This “disease in a dish” technique holds promise for not just Parkinson’s but a whole range of other disorders, including Type 1 diabetes, Huntington’s disease, Down syndrome and muscular dystrophy. Stanford scientists have even used the technique to build small faulty hearts to better understand rhythm disorders.

Genia Brin, an applied mathematician and retired research scientist at NASA’s Goddard Space Flight Center, was considered to be the perfect donor because she has the genetic form of the disease. Scientists reason that they would have a better chance of replicating the disorder with her cells, rather than the cells of someone with a more sporadic form of the disease. While rare, her form of the disease behaves just like the more common form, so it might offer important lessons.

This is what was promised from human cloning research.  That hasn’t worked—and we shouldn’t try.  That ethical line is easier to defend now that IPSCs are proving so valuable without having to risk women’s health by harvesting their eggs, or creating, and then destroying, embryos.

Dear Reader,

Can I be direct with you?

War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.

First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.

But we can’t do it without readers like you.

Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.


Your gift anchors readers in the permanent things.

Make your Fall Campaign gift now using the button below.

GIVE NOW

If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.

Next
YOU MIGHT ALSO LIKE

The Church in the Age of Therapy

Matthew Loftus

In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…

Canada’s Deadliest Blind Spot

Anna Farrow

On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…

The Faithful Joy of Dolly Parton and Fulton Sheen

Mike Aquilina

Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…